Publication | Closed Access

The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial

Metabolic SyndromeInsulin SensitivityDiabetes ManagementCardiovascular DiseaseMedicineInsulin ManagementDiabetesPhysiologyType 2PharmacotherapyDiabetes MellitusInsulin DeliveryEndocrinologyPharmacologyInsulin SignalingHealth Sciences